Загрузка...
Outcomes and Duration of Pneumocystis jirovecii Pneumonia Therapy in Infants with Severe Combined Immunodeficiency
This retrospective review of patients with severe combined immunodeficiency and Pneumocystis jirovecii pneumonia (PCP) evaluated the relationship between duration of therapy to treat PCP and overall survival. We found that 80% of patients receiving only 21 days of antibiotics survived to 12 months b...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3244569/ https://ncbi.nlm.nih.gov/pubmed/21817949 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0b013e31822db772 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|